MRAI
Marpai, Inc.
Price Chart
Latest Quote
$2.73
-0.09 (-3.19%)
Current Price
| Previous Close | $2.82 |
| Open | $2.90 |
| Day High | $2.90 |
| Day Low | $2.73 |
| Volume | 973 |
Stock Information
| Shares Outstanding | 26.83M |
| Total Debt | $29.51M |
| Cash Equivalents | $138K |
| Revenue | $16.64M |
| Net Income | $-16.89M |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Market Cap | $73.25M |
| EPS (TTM) | $-0.77 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $103.95M |
| Sales | $16.64M |
| Income | $-16.89M |
| Book/sh | $-1.46 |
| Cash/sh | $0.01 |
| Employees | 107 |
Financial Ratios
| Quick Ratio | 0.10 |
| Current Ratio | 0.38 |
Returns & Margins
| ROA | -82.78% |
| Gross Margin | 25.87% |
| Operating Margin | -82.41% |
| Profit Margin | -101.51% |
Ownership
| Insider Ownership | 53.99% |
| Institutional Ownership | 3.83% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -7.18 |
| P/S | 4.40 |
| P/B | -1.87 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.10 |
| SMA50 | $3.09 |
| SMA200 | $1.36 |
| RSI | 27.68 |
| ATR | 0.1581 |
| Shares Float | 14.34M |
| Short Float | 0.26% |
| Short Ratio | 0.11 |
| Volatility | 4.63 |
| Rel Volume | 0.07 |
Performance History
| Week | -10.14% |
| Month | -22.00% |
| Quarter | +21.88% |
| 6 Months | +907.38% |
| YTD | +307.46% |
| Year | +88.28% |
| 3 Years | +598.21% |
| 10 Years | -85.63% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-11-03 | $2.73 | 973 |
| 2026-11-02 | $2.78 | 23,400 |
| 2026-10-30 | $2.96 | 39,700 |
| 2026-10-29 | $3.06 | 19,600 |
| 2026-10-28 | $2.88 | 33,500 |
| 2026-10-27 | $3.04 | 10,200 |
| 2026-10-26 | $3.11 | 12,800 |
| 2026-10-23 | $3.13 | 4,000 |
| 2026-10-22 | $3.16 | 2,900 |
| 2026-10-21 | $3.20 | 2,000 |
| 2026-10-20 | $3.17 | 3,300 |
| 2026-10-19 | $3.18 | 9,900 |
| 2026-10-16 | $3.13 | 32,100 |
| 2026-10-15 | $3.19 | 12,100 |
| 2026-10-14 | $3.17 | 7,600 |
| 2026-10-13 | $3.20 | 2,100 |
| 2026-10-12 | $3.17 | 7,700 |
| 2026-10-09 | $3.28 | 52,300 |
| 2026-10-08 | $3.25 | 16,300 |
| 2026-10-07 | $3.26 | 5,500 |
| 2026-10-06 | $3.35 | 19,300 |
| 2026-10-05 | $3.50 | 13,600 |
About Marpai, Inc.
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company provides health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.
đ° Latest News
No news articles available at the moment. Check back later for updates on MRAI.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $22,737,533 | $16,537,405 | $10,189,418 |
| Cost Of Revenue | $24,239,117 | $17,136,330 | $10,289,578 |
| Total Revenue | $37,155,050 | $24,341,874 | $14,226,794 |
| Operating Revenue | $37,155,050 | $24,341,874 | $14,226,794 |
| Expenses | |||
| Interest Expense | $1,527,449 | $266,778 | $427,178 |
| Total Expenses | $63,527,968 | $51,025,299 | $30,088,042 |
| Other Income Expense | $-1,141,671 | $-39,319 | $153,591 |
| Other Non Operating Income Expenses | $488,869 | $234,472 | $172,513 |
| Net Non Operating Interest Income Expense | $-1,527,449 | $-266,778 | $-427,178 |
| Interest Expense Non Operating | $1,527,449 | $266,778 | $427,178 |
| Operating Expense | $39,288,851 | $33,888,969 | $19,798,464 |
| Other Operating Expenses | $8,306,447 | $7,385,622 | $3,081,986 |
| Selling And Marketing Expense | $6,596,981 | $6,938,513 | $4,965,209 |
| General And Administrative Expense | $19,176,895 | $12,318,529 | $8,055,572 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-28,751,900 | $-26,468,390 | $-15,984,835 |
| Net Interest Income | $-1,527,449 | $-266,778 | $-427,178 |
| Normalized Income | $-27,137,665 | $-26,199,801 | $-15,966,083 |
| Net Income From Continuing And Discontinued Operation | $-28,751,900 | $-26,468,390 | $-15,984,835 |
| Total Operating Income As Reported | $-27,976,983 | $-26,956,855 | $-15,861,248 |
| Net Income Common Stockholders | $-28,751,900 | $-26,468,390 | $-15,984,835 |
| Net Income | $-28,751,900 | $-26,468,390 | $-15,984,835 |
| Net Income Including Noncontrolling Interests | $-28,751,900 | $-26,468,390 | $-15,984,835 |
| Net Income Continuous Operations | $-28,751,900 | $-26,468,390 | $-15,984,835 |
| Pretax Income | $-29,042,038 | $-26,989,522 | $-16,134,835 |
| Special Income Charges | $-1,604,065 | $-273,430 | $0 |
| Operating Income | $-26,372,918 | $-26,683,425 | $-15,861,248 |
| Depreciation Amortization Depletion Income Statement | $3,896,833 | $3,538,237 | $1,961,733 |
| Depreciation And Amortization In Income Statement | $3,896,833 | $3,538,237 | $1,961,733 |
| Gross Profit | $12,915,933 | $7,205,544 | $3,937,216 |
| Per Share | |||
| Diluted EPS | $-4.14 | $-5.24 | $-6.36 |
| Basic EPS | $-4.14 | $-5.24 | $-6.36 |
| Other | |||
| Tax Effect Of Unusual Items | $-16,305 | $-5,202 | $-170 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-20,485,632 | $-22,311,791 | $-13,626,842 |
| Total Unusual Items | $-1,630,540 | $-273,791 | $-18,922 |
| Total Unusual Items Excluding Goodwill | $-1,630,540 | $-273,791 | $-18,922 |
| Reconciled Depreciation | $5,398,417 | $4,137,162 | $2,061,893 |
| EBITDA (Bullshit earnings) | $-22,116,172 | $-22,585,582 | $-13,645,764 |
| EBIT | $-27,514,589 | $-26,722,744 | $-15,707,657 |
| Diluted Average Shares | $6,951,669 | $5,059,959 | $2,519,123 |
| Basic Average Shares | $6,951,669 | $5,059,959 | $2,519,123 |
| Diluted NI Availto Com Stockholders | $-28,751,900 | $-26,468,390 | $-15,984,835 |
| Tax Provision | $-290,138 | $-521,132 | $-150,000 |
| Gain On Sale Of Ppe | $-335,106 | $-273,430 | $0 |
| Gain On Sale Of Business | $1,748,641 | $0 | - |
| Impairment Of Capital Assets | $3,017,600 | $0 | - |
| Gain On Sale Of Security | $-26,475 | $-361 | $-18,922 |
| Research And Development | $1,311,695 | $3,708,068 | $1,733,964 |
| Selling General And Administration | $25,773,876 | $19,257,042 | $13,020,781 |
| Other Gand A | $19,176,895 | $12,318,529 | $8,055,572 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-23,760,544 | $-10,614,720 | $15,512,948 |
| Total Assets | $31,679,014 | $49,949,620 | $44,201,640 |
| Total Non Current Assets | $14,594,065 | $23,411,771 | $17,209,633 |
| Other Non Current Assets | $21,668 | $21,668 | $28,333 |
| Non Current Prepaid Assets | $1,266,632 | $1,293,166 | $52,277 |
| Goodwill And Other Intangible Assets | $10,322,066 | $16,749,045 | $14,195,464 |
| Other Intangible Assets | $7,304,466 | $10,911,985 | $11,812,547 |
| Current Assets | $17,084,949 | $26,537,849 | $26,992,007 |
| Other Current Assets | $891,526 | $1,601,920 | $743,126 |
| Restricted Cash | $12,344,583 | $9,352,608 | $6,750,599 |
| Receivables | $2,702,039 | $1,818,813 | $315,238 |
| Other Receivables | $1,576,880 | $381,027 | $106,476 |
| Accounts Receivable | $1,125,159 | $1,437,786 | $208,762 |
| Allowance For Doubtful Accounts Receivable | $-24,617 | $-23,458 | $0 |
| Gross Accounts Receivable | $1,149,776 | $1,461,244 | $208,762 |
| Cash Cash Equivalents And Short Term Investments | $1,146,801 | $13,764,508 | $19,183,044 |
| Cash And Cash Equivalents | $1,146,801 | $13,764,508 | $19,183,044 |
| Prepaid Assets | - | - | $743,126 |
| Debt | |||
| Total Debt | $4,196,238 | $6,083,166 | $2,086,321 |
| Long Term Debt And Capital Lease Obligation | $3,683,822 | $4,771,871 | $1,301,828 |
| Current Debt And Capital Lease Obligation | $512,416 | $1,311,295 | $784,493 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $45,117,492 | $43,815,295 | $14,493,228 |
| Total Non Current Liabilities Net Minority Interest | $24,274,962 | $26,455,451 | $3,347,840 |
| Other Non Current Liabilities | $19,401,398 | $20,203,700 | $45,000 |
| Non Current Deferred Liabilities | $1,189,742 | $1,479,880 | $2,001,012 |
| Non Current Deferred Taxes Liabilities | $1,189,742 | $1,479,880 | $2,001,012 |
| Current Liabilities | $20,842,530 | $17,359,844 | $11,145,388 |
| Other Current Liabilities | $631,584 | $244,029 | $418,988 |
| Current Deferred Liabilities | $660,826 | $288,499 | $1,165,248 |
| Payables And Accrued Expenses | $17,835,559 | $14,326,723 | $8,298,359 |
| Payables | $4,648,837 | $1,460,871 | $1,129,543 |
| Accounts Payable | $4,648,837 | $1,457,670 | $1,125,906 |
| Equity | |||
| Common Stock Equity | $-13,438,478 | $6,134,325 | $29,708,412 |
| Total Equity Gross Minority Interest | $-13,438,478 | $6,134,325 | $29,708,412 |
| Stockholders Equity | $-13,438,478 | $6,134,325 | $29,708,412 |
| Retained Earnings | $-76,746,000 | $-47,994,100 | $-21,525,710 |
| Other | |||
| Ordinary Shares Number | $7,960,938 | $5,319,758 | $5,074,931 |
| Share Issued | $7,960,938 | $5,319,758 | $5,074,931 |
| Tangible Book Value | $-23,760,544 | $-10,614,720 | $15,512,948 |
| Invested Capital | $-13,438,478 | $6,134,325 | $29,708,412 |
| Working Capital | $-3,757,581 | $9,178,005 | $15,846,619 |
| Capital Lease Obligations | $4,196,238 | $6,083,166 | $2,086,321 |
| Total Capitalization | $-13,438,478 | $6,134,325 | $29,708,412 |
| Additional Paid In Capital | $63,306,726 | $54,127,893 | $51,232,092 |
| Capital Stock | $796 | $532 | $2,030 |
| Common Stock | $796 | $532 | $2,030 |
| Long Term Capital Lease Obligation | $3,683,822 | $4,771,871 | $1,301,828 |
| Current Deferred Revenue | $660,826 | $288,499 | $1,165,248 |
| Current Capital Lease Obligation | $512,416 | $1,311,295 | $784,493 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,202,145 | $1,433,327 | $897,288 |
| Current Accrued Expenses | $13,186,722 | $12,865,852 | $7,168,816 |
| Dueto Related Parties Current | $0 | $3,201 | $3,637 |
| Goodwill | $3,017,600 | $5,837,060 | $2,382,917 |
| Net PPE | $2,983,699 | $5,347,892 | $2,933,559 |
| Accumulated Depreciation | $-150,900 | $-649,745 | $-295,583 |
| Gross PPE | $3,134,599 | $5,997,637 | $3,229,142 |
| Leases | $0 | $745,453 | $621,527 |
| Other Properties | $2,513,729 | $4,244,485 | $2,265,846 |
| Machinery Furniture Equipment | $620,870 | $1,007,699 | $341,769 |
| Properties | $0 | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-15,749,206 | $-36,204,872 | $-12,535,547 |
| Operating Activities | |||
| Operating Cash Flow | $-15,749,206 | $-35,239,299 | $-10,795,252 |
| Cash Flow From Continuing Operating Activities | $-15,749,206 | $-35,239,299 | $-10,795,252 |
| Operating Gains Losses | $-1,171,982 | $273,430 | - |
| Investing Activities | |||
| Investing Cash Flow | $1,026,912 | $32,422,576 | $9,643,740 |
| Cash Flow From Continuing Investing Activities | $1,026,912 | $32,422,576 | $9,643,740 |
| Capital Expenditure Reported | $0 | $-602,805 | $-1,463,812 |
| Capital Expenditure | - | $-965,573 | $-1,740,295 |
| Net Other Investing Changes | - | $33,388,149 | $11,384,035 |
| Financing Activities | |||
| Issuance Of Capital Stock | $6,727,112 | $0 | $25,378,663 |
| Financing Cash Flow | $5,096,562 | $196 | $25,267,223 |
| Cash Flow From Continuing Financing Activities | $5,096,562 | $196 | $25,267,223 |
| Net Other Financing Charges | $-1,663,168 | - | $-831,577 |
| Net Common Stock Issuance | $6,727,112 | $0 | $25,378,663 |
| Common Stock Issuance | $6,727,112 | $0 | $25,378,663 |
| Other | |||
| End Cash Position | $13,491,384 | $23,117,116 | $25,933,643 |
| Beginning Cash Position | $23,117,116 | $25,933,643 | $1,817,932 |
| Changes In Cash | $-9,625,732 | $-2,816,527 | $24,115,711 |
| Proceeds From Stock Option Exercised | $32,618 | $196 | $953,394 |
| Net Business Purchase And Sale | $1,000,000 | $0 | - |
| Sale Of Business | $1,000,000 | $0 | - |
| Net PPE Purchase And Sale | $26,912 | $-362,768 | $-273,433 |
| Sale Of PPE | $26,912 | $0 | $0 |
| Purchase Of PPE | $0 | $-362,768 | $-273,433 |
| Change In Working Capital | $2,343,535 | $-16,063,164 | $1,579,290 |
| Change In Other Current Liabilities | $-1,549,601 | $-1,729,480 | $-139,856 |
| Change In Other Current Assets | $0 | $6,666 | $-28,333 |
| Change In Payables And Accrued Expense | $3,239,434 | $-14,696,740 | $2,217,358 |
| Change In Accrued Expense | $51,468 | $-14,875,371 | $2,431,954 |
| Change In Payable | $3,187,966 | $178,631 | $-214,596 |
| Change In Account Payable | $3,191,167 | $181,436 | $25,405 |
| Change In Prepaid Assets | $736,928 | $892,577 | $-346,910 |
| Change In Receivables | $-83,226 | $-536,187 | $-122,969 |
| Changes In Account Receivables | $-105,354 | $-597,051 | $-131,509 |
| Other Non Cash Items | $1,606,579 | $297,410 | $467,608 |
| Stock Based Compensation | $2,098,683 | $3,105,385 | $1,230,792 |
| Asset Impairment Charge | $3,017,600 | $0 | - |
| Deferred Tax | $-290,138 | $-521,132 | $-150,000 |
| Deferred Income Tax | $-290,138 | $-521,132 | $-150,000 |
| Depreciation Amortization Depletion | $5,398,417 | $4,137,162 | $2,061,893 |
| Depreciation And Amortization | $5,398,417 | $4,137,162 | $2,061,893 |
| Amortization Cash Flow | $3,556,160 | $3,140,767 | - |
| Amortization Of Intangibles | $3,556,160 | $3,140,767 | - |
| Depreciation | $1,842,257 | $996,395 | $2,061,893 |
| Gain Loss On Investment Securities | $241,553 | - | - |
| Gain Loss On Sale Of Business | $-1,748,641 | $0 | - |
| Net Income From Continuing Operations | $-28,751,900 | $-26,468,390 | $-15,984,835 |
| Repayment Of Debt | - | $0 | $-3,783,257 |
| Issuance Of Debt | - | $0 | $3,550,000 |
| Net Issuance Payments Of Debt | - | $0 | $-233,257 |
| Net Short Term Debt Issuance | - | $0 | $0 |
| Short Term Debt Payments | - | $0 | $-3,000,000 |
| Short Term Debt Issuance | - | $0 | $3,000,000 |
| Net Long Term Debt Issuance | - | $0 | $-233,257 |
| Long Term Debt Payments | - | $0 | $-783,257 |
| Long Term Debt Issuance | - | $0 | $550,000 |
| Net Intangibles Purchase And Sale | - | $0 | $-3,050 |
| Purchase Of Intangibles | - | $0 | $-3,050 |
Fetched: 2026-02-02